Back

Quantitative assessment of pericardial delayed hyperenhancement: have we finally found an objective criteria to diagnose and treat recurrence?

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Pericardial disease - Tumours of the heart Pericardial and myocardial disease, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Arnav Kumar

University of Texas Medical Branch, Galveston (United States of America)

11 More presentations in this session

Presentation thumbnail
Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids?
Doctor A. Mager (Petah Tikva, IL)
Abstract
Presentation thumbnail
Meta-analysis for the value of colchicine for the therapy and prevention of recurrence of pericarditis, and for rehospitalization for pericarditis and postpericardiotomy syndrome.
Assistant Professor M. Noutsias (Berlin, DE)
Abstract Slides
Presentation thumbnail
Epicardial fat volume quantification by computed tomography predicts long-term outcome in patients with acute pericarditis
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Novel echocardiographic prognostic markers for cardiac tamponade in patients with large malignant pericardial effusions. A paradigm shift from flow to tissue imaging.
Doctor G. Chalikias (Alexandroupolis, GR)
Abstract Slides
Presentation thumbnail
Factors predicting non-steroidal drugs failure and switch to corticosteroid treatment in patients with acute pericarditis
Doctor G. Lazaros (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Pericardial disease - Tumours of the heart

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources